Top compounds associated with response to CRYGS


Feature Type Standardized
Nominal ANOVA
mRNA XAV-939 GDSC1000 pan-cancer AAC -0.079 0.03
mRNA VX-702 GDSC1000 pan-cancer AAC 0.081 0.03
mRNA TAE684 GDSC1000 pan-cancer AAC -0.12 0.03
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.075 0.03
mRNA GSK461364 CTRPv2 pan-cancer AAC 0.066 0.03
mRNA KIN001-236 GDSC1000 pan-cancer AAC 0.076 0.03
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.071 0.03
mRNA QL-X-138 GDSC1000 pan-cancer AAC 0.069 0.04
mRNA SU11274 CTRPv2 pan-cancer AAC 0.073 0.04
mRNA BRD6340 CTRPv2 pan-cancer AAC 0.072 0.04
Download CSV